Cardiovascular and Metabolic Disorders Feature Archive
A patient living near an area experiencing frequent wildfires is concerned about the potential negative effect that the wildfires may have on his health.
Although the use of fertility therapy has steadily increased in the past few decades, research findings pertaining to related long-term cardiovascular outcomes are scarce and conflicting.
A man presents to the emergency department having had palpitations for the past week, and he has a medical history of hypertension, obesity, and hyperlipidemia. What's the diagnosis?
The AHA now recommends replacing both saturated and trans fats with unsaturated fats from vegetable oils, nuts, seeds, and oily fish.
Primary prevention of cardiovascular disease through risk factor modification, including tobacco cessation, maintenance of a body mass index, and management of abnormal lipid levels, diabetes, and hypertension, is of great importance for the health of transgender individuals.
Subclinical thyroid dysfunction did not influence the cumulative incidence of new carotid plaques in healthy individuals aged 20 or older.
Despite multiple measures and goals to reduce US maternal mortality rates, the latest data suggest the United States is far behind the rest of the world in maternal health care.
The new guidelines call for treating low-density lipoprotein cholesterol in specific patient groups to lower goals than previously recommended.
Even if the impact of a given medication on lipid profile is relatively minimal, and therefore unlikely to independently affect ASCVD risk, the cumulative effect is important and cannot be overlooked.
A recent investigation found that very low sodium intake may actually increase the risk for CVD and mortality.
A range of pharmacologic agents have a potential role in the management of NAFLD.
Even the addition of a cash incentive did not result in significant health benefits for patients using activity trackers.
Researchers found the cardiovascular safety of semaglutide was noninferior to placebo in high-risk patients with type 2 diabetes.
A historical analysis shows the Sugar Research Foundation may have influenced a review from Harvard researchers that downplayed the risks of sugar.
Adhering to the Mediterranean diet may stave off certain diseases, but the benefit on mortality remains questionable.
In light of ELITE trial results, estradiol hormone therapy may have a role in coronary heart disease treatment.
Compared with placebo, liraglutide decreased the rate of cardiovascular events in high-risk patients with diabetes.
Data on cardiovascular benefits as well as adverse effects have thrust this class of diabetes drugs into the spotlight.
Patients with diabetes not only had shorter life expectancy but also lived with disabilities longer than the general population.
Results from HOPE-3 suggest statins can be more widely used in intermediate-risk patients without cardiovascular disease.
Sedentary behaviors may boost risk for type 2 diabetes by 22% and risk for metabolic syndrome by 39%.
Findings did not establish the prespecified margin of noninferiority after unplanned early termination.
Patients with cardiovascular disease are 3 times more likely to develop depression, which makes psychosocial health monitoring essential.
Exercise's potential positive effects on cardiovascular disease and heart failure may be possible regardless of frequency and time of initiation.
Although many clinicians applaud the big-picture approach of the new guidelines, some have taken issue with certain recommendations.
Results from the SPRINT trial, reported at the American Heart Association, suggest that lower systolic blood pressure targets may be more effective in lowering cardiovascular risk.
The American Association of Clinical Endocrinologists' updated algorithm for type 2 diabetes management addresses lifestyle modifications and obesity treatments.
Central obesity in people with normal weight may increase the risk for premature mortality vs BMI-defined overweight or obesity.
Results showed a consistent benefit in both patients with and those without heart failure.
Weight, metabolic health, and overall quality of life improved 3 years after bariatric surgery.
With no established guidelines, much of the decisions for management of hypertension during stroke are based on clinician experience.
PCSK9 antibodies can safely and effectively treat high cholesterol in adults while reducing mortality rates.
New imaging techniques show promise for diagnosing NAFLD.
The first step in reducing the risk for cardiovascular disease is for health care professionals to get a full understanding of a patient's risk.
The American College of Cardiology and American Heart Association guidelines prompt significant changes in lipid management.
Endocrinology Advisor Articles
- Predictors of Success for Insulin-to-Liraglutide Switch for Type 2 Diabetes
- Efficacy and Safety of Alirocumab in Diabetes Mellitus
- Safety of DPP-IV Inhibitor, Cardiovascular Events After ACS in Type 2 Diabetes
- Transgender Youth Not Willing to Delay Hormone Therapy for Fertility Preservation
- Pre-Pregnancy Programs May Improve Outcomes in Women With Type 2 Diabetes
- Diabetes Treatments
- Metformin May Decrease Colorectal Cancer Risk Among Males With Diabetes
- SGLT2 Inhibitor, GLP-1 Receptor Agonist Combination Treatment for Type 2 Diabetes: Expert Insights
- Semaglutide May Induce Weight Loss in Type 2 Diabetes Despite BMI
- FDA Clears Omnipod DASH System for Diabetes Management
- IV Fluid Infusion Rates Do Not Affect Pediatric DKA Neurologic Outcomes
- Effect of Fructose, Allulose on Postprandial Glucose Regulation in Type 2 Diabetes
- Psychiatric Morbidity Decreased After Assisted Reproductive Technology Treatment
- Fenofibrate Improves Cholesterol Levels in Type 2 Diabetes
- Sex Hormone Levels May Affect Postmenopausal Heart Disease Risk